Pacritinib-d4

CAT: 0804-HY-16379S-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-16379S-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Pacritinib-d8 (SB1518-d8) is the deuterium labeled Pacritinib (HY-16379) . Pacritinib (SB1518) is a potent inhibitor of both wild-type JAK2 (IC50=23 nM) and JAK2V617F mutant (IC50=19 nM) . Pacritinib also inhibits FLT3 (IC50=22 nM) and its mutant FLT3D835Y (IC50=6 nM) .
Product Name Alternative
SB1518-d4
UNSPSC
12352005
Target
FLT3; Isotope-Labeled Compounds; JAK
Related Pathways
Epigenetics; JAK/STAT Signaling; Others; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Cancer
Purity
98.42
Smiles
[2H]C(CCC1([2H])[2H])([2H])N1CCOC(C=C2)=C3COC/C=C/COCC4=CC=CC(C5=N/C(NC=C5)=N\C2=C3)=C4
Molecular Formula
C28H28D4N4O3
Molecular Weight
476.60
References & Citations
[1]William AD, et al. Discovery of the macrocycle 11- (2-pyrrolidin-1-yl-ethoxy) -14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1 (2,6) .1 (8,12) ]heptacosa-1 (25),2 (26),3,5,8,10,12 (27),16,21,23-decaene (SB1518), a potent Janus kinase 2/fms-like tyrosine kinase-3 (JA|[2]Hart S, et al. Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia. Blood Cancer J. 2011 Nov;1 (11) :e44.|[3]Hart S, et al. SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies. Leukemia. 2011 Nov;25 (11) :1751-9.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-16379-01Pacritinib
HY-16379B-01Pacritinib (citrate)
HY-16379R-01Pacritinib (Standard)
HY-16379APacritinib (hydrochloride)
HY-151912S-01Picolinafen-d4 (4-Fluorophenyl-d4)
HY-W654154Dexmedetomidine-d4 L-tartrate (-d4-major)
HY-151892SGlimepiride-d4 (phenylethyl-α, α, β, β-d4) (cis/trans)
HY-151910S(±) -Fluoxetine-d4 Oxalate (trifluoromethylphen-d4-oxy)
HY-132468SKeto Pioglitazone-d4 (M-III-d4)
HY-151117SMethylacetylene-d4

Alternative Products

CatalogName
461939-01Pacritinib
MBS578596Pacritinib (SB1518)
MBS5806943Pacritinib hydrochloride
2450-5SB1518 (Pacritinib)
B2485-1EZSolution™ Pacritinib
T87094-01Pacritinib citrate
TMID-0049-01Pacritinib-d8
A12694-2Pacritinib (SB1518) 2mg
A12694-5Pacritinib (SB1518) 5mg
SD4762-25mgPacritinib (JAK inhibitor)

Popular Products